Blog Voices from the Frontlines

Jun 142017

Science Calls Out Jeff Sessions on Medical Marijuana and the "Historic Drug Epidemic"

SCIENTIFIC-AMERICAN.pngAmid a drug crisis that kills 91 people in the U.S. each day, Attorney General Jeff Sessions has asked Congress to help roll back protections that have shielded medical marijuana dispensaries from federal prosecutors since 2014, according to a letter made public this week. Those legal controls—which bar Sessions’s Justice Department from funding crackdowns on the medical cannabis programs legalized by 29 states and Washington, D.C.—jeopardize the DoJ’s ability to combat the country’s “historic drug epidemic” and control dangerous drug traffickers, the attorney general wrote in the letter sent to lawmakers.

Read More

Jun 132017

If You Don’t Think Jeff Sessions is a Threat You’re Not Paying Attention - Americans for Safe Access

On Monday, a letter from  Attorney General Jeff Sessions that highlights his opposition to medical cannabis became public.  While the Administration had previously given somewhat vague statements about their intentions relating to medical cannabis, this letter provides clear cut opposition to appropriations riders that prevent the Department of Justice from expending funds against medical cannabis activities. The letter requested that leaders of congress not restrict the Department of Justice’s funding in the prosecution of state medical cannabis laws.

Jun 122017

International Cannabis Standards Committee Launched by ASTM and APHA - Americans for Safe Access

Americans for Safe Access’s Patient Focused Certification standards for medical marijuana accepted as foundational recommendations

Last week, global standards organization ASTM International and the American Herbal Products Association (AHPA) announced that they will develop standards for the cannabis industry. Under the agreement, ASTM International will coordinate standards development activities for the cannabis industry, while AHPA will gain recognition for its technical contributions and regulatory recommendations. The AHPA standards are the basis of the Patient Focused Certification (PFC) program that is used internationally to assess regulatory compliance at medical cannabis operations, and to educate the medical cannabis industry and program administrators.

Jun 022017

“No More Delays” Rally in Baltimore a Success - Americans for Safe Access

D355ebec9-8889-44b5-a748-c80dc08aab6b.jpgozens of medical cannabis patients and industry advocates gathered this morning in front of the courthouse in Baltimore, Maryland to protest further delays to the state’s medical cannabis program.  The potential delays came from a restraining order issued by a Circuit Court Judge, preventing the Maryland Medical Cannabis Commission (MMCC) from awarding any further licenses. The restraining order was initiated as a result of allegations by a company not awarded a contract that the MMCC discriminated against minority-owned businesses. To date, the commission has only issued one license to a medical cannabis business.

Jun 022017

Physicians, Patients, Members of Americans for Safe Access Rally to Protect Access to Medical Cannabis in Maryland - Americans for Safe Access

Baltimore, MD — On Friday, June 2nd,  physicians, cannabis industry professionals, and members of Americans for Safe Access will rally to protect patient access to medical cannabis throughout Maryland State. After more than four years since its legalization, medical cannabis patients are now months away from accessing prescribed medicinal cannabis in Maryland, unless Baltimore City Circuit Court decides to halt licensing of medical cannabis growers.

Jun 012017

Safe Access Tennessee Launches Grassroots Patient Membership Groups - Americans for Safe Access

NASHVILLE, TENNESSEE -- Americans for Safe Access (ASA), the nation’s largest patient-focused medical cannabis advocacy organization, is pleased to announce new membership opportunities for medical cannabis patient advocates in Tennessee. 

May 252017

Approval of the First Medical Cannabis Grow Operation in Maryland Granted to Patient Focused Certified Company - Americans for Safe Access

Maryland regulators issued the first license to grow medical cannabis in Maryland to ForwardGro, a company with a 1-acre greenhouse located in Anne Arundel County. This decision comes more than four years after Maryland first approved a medical cannabis program. ForwardGro is also the first company in Maryland to be certified for cultivation under American for Safe Access’ (ASA) Patient Focused Certification (PFC) program. 

Read More

May 252017

Hawai‘i Gets a “B” for Medical Marijuana Program - Americans for Safe Access

By Maui Now

Hawaiʻi Department of Health has received a “B” and was ranked the fifth highest in the nation for its medical marijuana program, based on a recent report card of new, regulated medical marijuana distribution programs issued by Americans for Safe Access.

The national organization’s mission is to reduce barriers to medical cannabis by creating policies to improve access for patients and researchers, using legislation, education, litigation, research and other means.

According to the report card, “Hawaiʻi is on track to become one of the best programs in the country if they continue with their timely implementation.”

May 242017

Approval of the First Medical Cannabis Grow Operation in Maryland Granted to Patient Focused Certified Company - Americans for Safe Access

Last week, Maryland regulators issued the first license to grow medical cannabis in Maryland to ForwardGro, a company with a 1-acre greenhouse located in Anne Arundel County. This decision comes more than four years after Maryland first approved a medical cannabis program.

May 162017

Medical cannabis under Trump's first 100 days - Americans for Safe Access

By Steph Sherer for The Hill

The phrase “no news is good news” should mean an assurance that a situation is not dramatically worsening, and perhaps even improving. For the first 100 days of Trump’s Presidency, the lack of news surrounding medical cannabis has been, for the most part, good news for the status quo. However, this is not a comfort to medical cannabis patients for whom behind the scenes actions could upend, disrupt, or delay access to their medication.